Pancreatic Cancer Research

ResearcherAmgen (United States)No recent work listed

Ian McCaffery

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6697-0961; OpenAlex author ID A5059195446. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2013: 2 papers

Papers 2

  1. Differential Pharmacokinetics of Ganitumab in Patients With Metastatic Pancreatic Cancer Versus Other Advanced Solid Cancers. Co-author DOI 10.1002/cpdd.48↗
  2. Putative predictive biomarkers of survival in patients with metastatic pancreatic adenocarcinoma treated with gemcitabine and ganitumab, an IGF1R inhibitor. Co-author DOI 10.1158/1078-0432.ccr-12-1840↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Min Zhu · 1 shared paper, 2013 · strength 0.04
  2. Jianfeng Lü · 1 shared paper, 2013 · strength 0.04
  3. Jennifer L. Gansert · 1 shared paper, 2013 · strength 0.03
  4. Hedy Lee Kindler · 1 shared paper, 2013 · strength 0.03
  5. Charles S. Fuchs · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.